Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
142.7 USD | -3.16% | -2.57% | +21.72% |
May. 29 | BofA Securities Adjusts Crane Price Target to $165 From $140, Maintains Buy Rating | MT |
May. 27 | CR Double-Crane Pharmaceutical's Unit Gets Nod for Phloroglucinol Injection | MT |
- Stock Market
- Equities
- CR Stock
- News Crane Company
- Other languages